7CC Stock Chart & Stats
€5.55
€0.26(20.80%)
At close: 4:00 PM EST
€5.55
€0.26(20.80%)
Day’s Range― - ―
52-Week Range€3.26 - €18.62
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€50.63M
Enterprise Value-€3.25
Total Cash (Recent Filing)€265.00K
Total Debt (Recent Filing)€136.00K
Price to Earnings (P/E)0.8
Beta1.02
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding15,293,584
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)2.94
Price to Sales (P/S)0.00
P/FCF Ratio-219.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€8.78Price Target Upside58.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Potential Revenue StreamsThe potential for revenue through product sales, partnerships, and licensing agreements could provide significant growth opportunities, especially as the company seeks regulatory approvals and market expansion.
Innovative Product OfferingThe C-Scan technology represents a novel approach in colorectal cancer screening, potentially offering a competitive advantage in the medical diagnostics industry by providing a patient-friendly, preparation-free option.
Strong Equity PositionA strong equity position with no debt provides financial stability and flexibility, allowing the company to potentially weather financial challenges and invest in growth opportunities without the burden of debt repayments.
Bears Say
Persistent LossesOngoing losses highlight financial instability and the difficulty in achieving profitability, which may limit the company's ability to attract investment and sustain operations without external funding.
Negative Cash FlowsPersistent negative cash flows indicate ongoing operational challenges, which can deplete cash reserves over time and hinder the company's ability to invest in growth or respond to market opportunities.
Lack Of Revenue GenerationThe absence of revenue generation poses a significant risk to the company's long-term sustainability, as it relies on its cash reserves without generating income to support operations and growth.
7CC FAQ
What was MBody AI Ltd’s price range in the past 12 months?
MBody AI Ltd lowest stock price was €3.26 and its highest was €18.62 in the past 12 months.
What is MBody AI Ltd’s market cap?
MBody AI Ltd’s market cap is €50.63M.
When is MBody AI Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MBody AI Ltd’s earnings last quarter?
Currently, no data Available
Is MBody AI Ltd overvalued?
According to Wall Street analysts MBody AI Ltd’s price is currently Undervalued.
Does MBody AI Ltd pay dividends?
MBody AI Ltd does not currently pay dividends.
What is MBody AI Ltd’s EPS estimate?
MBody AI Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MBody AI Ltd have?
MBody AI Ltd has 15,293,584 shares outstanding.
What happened to MBody AI Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MBody AI Ltd?
Currently, no hedge funds are holding shares in DE:7CC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MBody AI Ltd Stock Smart Score
Company Description
MBody AI Ltd
MBody AI Ltd. designs and develops embodied artificial intelligence software for autonomous workforce and operational automation. The company's platform provides Perception AI for computer vision and environmental understanding, Cognitive AI for adaptive decision-making, and Learning AI for continuous on-site machine learning. Its platform also provides dynamic task and route optimization, along with fleet intelligence and coordination across multi-unit operations. The company serves the hospitality, office, warehouse, and healthcare sectors, supporting applications such as facility maintenance, workspace cleaning, autonomous logistics, inventory management, and sanitation. MBody AI Ltd. was founded in 2004 and is based in Mississauga, Canada.
7CC Stock 12 Month Forecast
Average Price Target
€8.78
▲(58.19% Upside)
Technical Analysis
Intelligent Bio Solutions
―
iSpecimen
―
BioNexus Gene Lab Corp
―
―
bioAffinity Technologies, Inc.
―









